Comments on: Three pharmaceutical shares trialing and developing coronavirus treatments https://ukinvestormagazine.co.uk/three-pharmaceutical-shares-trialing-and-developing-coronavirus-medicines-and-treatments/ UK Investor Magazine provides breaking financial news and investment ideas Mon, 08 Jun 2020 11:16:50 +0000 hourly 1 https://wordpress.org/?v=6.8.5 By: AstraZeneca approaches Gilead over possible merger - UK Investor Magazine https://ukinvestormagazine.co.uk/three-pharmaceutical-shares-trialing-and-developing-coronavirus-medicines-and-treatments/#comment-15390 Mon, 08 Jun 2020 11:16:50 +0000 https://ukinvestormagazine.co.uk/?p=28102#comment-15390 […] Gilead’s anti-viral drug, Remdesivir, received emergency approval from the FDA after a number of trials found positive effects in patients with severe COVID-19. Despite the positive results, other studies found little or no positive effects and there is some scepticism around the long term impact of the drug. […]

]]> By: Novacyt continues to provide opportunity in the face of uncertainty - UK Investor Magazine https://ukinvestormagazine.co.uk/three-pharmaceutical-shares-trialing-and-developing-coronavirus-medicines-and-treatments/#comment-14806 Tue, 17 Mar 2020 13:01:38 +0000 https://ukinvestormagazine.co.uk/?p=28102#comment-14806 […] this has investors excited, some analysts are cautioning that Novacyt are not alone in the pursuit of testing kit […]

]]>